Stelara (Ustekinumab) for the Treatment of Moderate to Severe Crohn ’s Disease
Developed by Janssen Biotech, Stelara (Ustekinumab) is indicated for the treatment of moderate to severely active Crohn's disease.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news